Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy

Name: Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
License: Public Domain

ikfe-CRO GmbH

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus type ii

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272310
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.